hsbc bank plc programme for the issuance of …...final terms dated: 28 september 2017 series no.:...

Final Terms dated: 28 September 2017 Series No.: APAC1189 Tranche No.: 1

HSBC Bank plc

Programme for the Issuance of Notes and Warrants

Issue of

12,000,000 Market Access Warrants linked to ordinary A shares issued by Meinian Onehealth Healthcare Holdings Co Ltd (the "Underlying Security") due November 2020 (the “Warrants”)

PART A – CONTRACTUAL TERMS

This document constitutes the Final Terms relating to the issue of the Tranche of Warrants described herein. Terms used herein shall be deemed to be defined as such for the purposes of the terms and conditions of the Warrants (the "Conditions") set forth in the Base Prospectus dated 1 June 2017 in relation to the above Programme, together with each supplemental prospectus relating to the Programme published by the Issuer after 1 June 2017 but before the issue date or listing date of the Warrants, whichever is later, to which these Final Terms relate which together constitute a base prospectus ("Prospectus") for the purposes of the Prospectus Directive (Directive 2003/71/EC, as amended) (the "Prospectus Directive"). This document constitutes the Final Terms of the Warrants described herein for the purposes of Article 5.4 of the Prospectus Directive and must be read in conjunction with such Prospectus. However, a summary of the issue of the Warrants is annexed to these Final Terms.

Full information on the Issuer and the offer of the Warrants is only available on the basis of the combination of these Final Terms and the Prospectus. The Prospectus is available for viewing during normal business hours at HSBC Bank plc, 8 Canada Square, London E14 5HQ, United Kingdom and www.hsbc.com (please follow links to 'Investor relations', 'Fixed income investors', 'Issuance programmes') and copies may be obtained from HSBC Bank plc, 8 Canada Square, London E14 5HQ, United Kingdom.

1. Issuer: HSBC Bank plc

2. (i) Tranche Number:

1

(ii) Whether issue is of Warrants or Certificates:

Warrants.

3. Settlement Currency: United States Dollars (“USD”)

4. Aggregate number of Warrants:

(i) Series: 12,000,000 Warrants

(ii) Tranche: 12,000,000 Warrants

5. Face Value: USD2.5500 per Warrant

6. Issue Price: USD2.5500 per Warrant

7. Issue Date: 28 September 2017

8. Style of Warrants: The Warrants are American Style Warrants. Condition 4(a) is applicable.

- 2 -

9. (i) Expiry Date: 23 November 2020

(ii) Automatic Exercise:

Applicable

(iii) Exercise Period: The period beginning from (and including) the Issue Date and ending on (and including) the Expiry Date.

(iv) Potential Exercise Date(s):

Not Applicable

10. (i) Minimum Exercise Number:

1 Warrant

(ii) Permitted Multiple:

1 Warrant

11. Cash Settlement Payment Date:

as per Condition 7(b)

12. Type of Warrants: Underlying Security-Linked Warrant

13. Default Rate: Not Applicable

14. Buy-Back provisions: Applicable

15. Exercise Commission Percentage:

1.00%

16. Additional Payments for Underlying Index-Linked Warrants:

Not applicable

17. (i) Administration Fee:

Not applicable

(ii) Administration Fee Rate:

Not applicable

18. Strike Price: USD 0.000001

PROVISIONS APPLICABLE TO EQUITY-LINKED WARRANTS AND INDEX-LINKED WARRANTS

19. Provisions for Underlying Equity-Linked Warrants:

Applicable

(a) Underlying Security-Linked Warrants:

Applicable

- 3 -

Underlying Securities (including ISIN or other security identification code)

Underlying Companies

Number of Underlying Securities

per Warrant Exchange(s)

Related Exchange(s)

Underlying Currency

China Connect

Underlying / PRC

Underlying / PRC

Underlying that is B-

Shares

Ordinary A shares of Meinian

Onehealth Healthcare

Holdings Co Ltd (ISIN:

CNE000001 LV7)

Meinian Onehealth Healthcare

Holdings Co Ltd

1 Shenzhen Stock

Exchange

All Exchanges Renminbi (“CNY”)

PRC Underlying

(i) Underlying Security(ies):

As specified in the above table

(ii) Underlying Company(ies):


(iii) Exchange(s): As specified in the above table

(iv) Related Exchange(s): As specified in the above table

(v) Underlying Currenc(y)ies:


(vi) China Connect Underlying:

No

(vii) PRC Underlying: Yes

(viii) PRC Underlying that is B-shares:

No

(ix) Additional Disruption Events:

Change in Law

Insolvency Filing

Hedging Disruption

Increased Costs of Hedging

Currency Event

(b) Underlying Fund-Linked Warrants:

Not applicable

(c) Underlying ETF-Linked Warrants:

Not applicable

20. Provisions for Underlying Index-Linked Warrants:

Not applicable

21. Further provisions applicable to Underlying Index-Linked Warrants:

Not applicable

22. Valuation Date(s): Exercise Date

- 4 -

23. Valuation Time: The definition in the Conditions applies

GENERAL PROVISIONS APPLICABLE TO THE WARRANTS

24. Form of Warrants:

- Initially represented by: Combined Global Registered Warrant

25. Payments:

(i) Relevant Financial Centre Day:

New York

(ii) Business Centre(s): New York and London

(iii) Payment of Alternative Payment Currency Equivalent:

Not applicable

Alternative Payment Currency:

Not applicable

Alternative Payment Currency Jurisdiction:

Not applicable

Settlement Currency Jurisdiction:

Not applicable

Alternative Payment Currency Fixing Page:

Not applicable

Alternative Payment Currency Fixing Time:

Not applicable

Alternative Payment Currency Exchange Rate Fall-Back provisions:

Not applicable

Offshore RMB Centre: Not applicable

26. Redenomination: Not applicable

27. Supplementary Amount: Not applicable

CONFIRMED

HSBC BANK plc

By: . Authorised Signatory

Date: ......................................................................

- 5 -

PART B – OTHER INFORMATION

LISTING

1. (i) Listing: Application will be made to admit the Warrants to listing on the Official List of the United Kingdom Financial Conduct Authority. No assurance can be given as to whether or not, or when, such application will be granted.

(ii) Admission to trading:

Application will be made for the Warrants to be admitted to trading on the regulated market of the London Stock Exchange plc. No assurance can be given as to whether or not, or when, such application will be granted.

2. REASONS FOR THE OFFER AND USE OF PROCEEDS, ESTIMATED NET PROCEEDS AND TOTAL EXPENSES

(i) Reasons for the offer and use of proceeds:

Not applicable

(ii) Estimated net proceeds:

Information not provided

(iii) Estimated total expenses:

Information not provided

3. INTERESTS OF NATURAL AND LEGAL PERSONS INVOLVED IN THE ISSUE

Save for any fees payable to the Manager(s), so far as the Issuer is aware, no person involved in the issue of the Warrants has an interest material to the issue. The Manager(s) and their affiliates have engaged, and may in the future engage, in investment banking and/or commercial banking transactions with, and may perform other services for, the Issuer and its affiliates in the ordinary course of business.

4. INFORMATION ABOUT THE UNDERLYING

Details of past and further performance and volatility of the Underlying Securities are obtainable from the following display pages on Bloomberg and such information does not form part of this document: (Source: Bloomberg Financial Markets Information Service) 002044 CH. Details relating to the Underlying Securities are available on the following website of the issuer of such Underlying Securities: www.health-11.cn The Issuer confirms that the information sourced from Bloomberg Financial Markets Information Service has been accurately reproduced. As far as the Issuer is aware and is able to ascertain from information available from such source, no facts have been omitted which would render the reproduced information inaccurate or misleading.

OPERATIONAL INFORMATION

5. ISIN: GB00BZY3HX12

6. Common Code: 169294992

7. SEDOL: Not applicable

8. CUSIP: Not applicable

9. Valoren Number: Not applicable

10. Clearing System: Euroclear and Clearstream, Luxembourg

- 6 -

11. Additional U.S. federal income tax considerations:

The Warrants are not Section 871(m) Warrants for the purpose of Section 871(m).

12. Principal Warrant Agent/Registrar/Issue Agent/Transfer Agent:

HSBC Bank plc

13. Additional Warrant Agent(s) (if any):

Not applicable

14. Calculation Agent: HSBC Bank plc

- 7 -

ANNEX

ADDITIONAL PROVISIONS NOT REQUIRED BY THE SECURITIES NOTE RELATING TO THE UNDERLYING

INFORMATION ABOUT THE SECURITY

The information set out in this Annex relating to Lepu Medical Technology Co., Ltd.Meinian Onehealth Healthcare Holdings Co Ltd (the "Underlying Company") (Bloomberg: 002044 CH) provides a brief discussion of the business of the Underlying Company and the split-adjusted high, low and end-of-period closing prices for each Security for each calendar quarter in the period from 29 June 2012 to 30 June 2017 and from 15 September 2017 to 21 September 2017. The Issuer confirms that the information set out in this Annex relating to the ordinary A shares of the Underlying Company (the "Security") has been accurately reproduced from Bloomberg Financial Markets Information Service. As far as the Issuer is aware and is able to ascertain from information available from such source, no facts have been omitted which would render the reproduced information inaccurate or misleading.

1. Description of the Underlying Company (Source: Bloomberg Financial Markets Information Service

The Underlying Company is incorporated in the PRC.

The Underlying Company operates in the medical industry. The Underlying Company offers health examination, evaluation, and consulting services throughout China.

2. Listing

The Security is listed on the Shenzhen Stock Exchange.

3. Historical prices

Date PX_HIGH (CNY) PX_LOW (CNY) PX_LAST (CNY)

6/29/2012 3.884609 3.273384 3.355 9/28/2012 3.676262 2.862759 3.669 12/31/2012 3.935809 2.227451 2.809 3/29/2013 3.164917 2.688436 2.801 6/28/2013 3.25727 2.223406 2.223 9/30/2013 2.814185 2.355134 2.611 12/31/2013 3.101592 2.634557 2.806 3/31/2014 2.941922 2.474886 2.475 6/30/2014 2.578672 2.371101 2.547 9/30/2014 4.152079 2.599073 4.039 12/31/2014 #N/A N/A #N/A N/A 4.039 3/31/2015 5.910276 4.441759 5.91 6/30/2015 30.45815 6.501706 27.471 9/30/2015 23.79512 13.06134 15.419 12/31/2015 #N/A N/A #N/A N/A 15.419 3/31/2016 #N/A N/A #N/A N/A 15.419 6/30/2016 15.03428 13.0064 14.455 9/30/2016 15.62366 12.93647 13.826 12/30/2016 14.54479 12.32711 13.166 3/31/2017 14.39495 11.99745 13.925 6/30/2017 17 14.23511 17

- 8 -

9/15/2017 17 16.82 16.95 9/18/2017 17.34 16.8 17.11 9/19/2017 17.31 17.02 17.15 9/20/2017 17.28 16.01 17.08 9/21/2017 17.06 16.69 16.77

The historical prices of a Security should not be taken as an indication of future performance, and no assurance can be given that the price of a Security will perform sufficiently from year to year to cause the holders of the Warrants to receive any return on their investment.

- 9 -

ISSUE SPECIFIC SUMMARY

Section A – Introduction and Warnings

A.1 Introduction and Warnings:

This summary must be read as an introduction to the prospectus and any decision to invest in the Warrants should be based on a consideration of the prospectus as a whole by the investor, including any information incorporated by reference and read together with the relevant final terms.

Where a claim relating to the information contained in the prospectus is brought before a court in a Member State of the European Economic Area, the claimant may, under the national legislation of the Member States, be required to bear the costs of translating the prospectus before the legal proceedings are initiated.

Civil liability attaches only to those persons who have tabled this summary including any translation thereof, but only if this summary is misleading, inaccurate or inconsistent when read together with the other parts of the prospectus or it does not provide, when read together with the other parts of the prospectus, key information in order to aid investors when considering whether to invest in the Warrants.

A.2 Consent by the Issuer to the use of the prospectus in subsequent resale or final placement of the securities, indication of offer period and conditions to consent for subsequent resale or final placement and warning:

Not applicable. The prospectus has been prepared solely in connection with the admission of Warrants to trading on a regulated market pursuant to Article 3(3) of the Prospectus Directive and there will be no public offer of the Warrants. The Issuer does not consent to the use of the prospectus for subsequent resales.

Section B – Issuer

B.1 Legal and commercial name of the Issuer:

The legal name of the issuer is HSBC Bank plc (the "Issuer") and, for the purposes of advertising, the Issuer uses an abbreviated version of its name, HSBC.

B.2 Domicile and legal form of the Issuer, the legislation under which the Issuer operates and its country of incorporation:

The Issuer is a public limited company registered in England and Wales under registration number 14259. The liability of its members is limited. The Issuer was constituted by Deed of Settlement on 15 August 1836 and in 1873, registered under the Companies Act 1862 as an unlimited company. It was re-registered as a company limited by shares under the Companies Acts 1862 to 1879 on 1 July 1880. On 1 February 1982 the Issuer re-registered under the Companies Acts 1948 to 1980 as a public limited company.

- 10 -


The Issuer is subject to primary and secondary legislation relating to financial services and banking regulation in the United Kingdom, including, inter alia, the UK Financial Services and Markets Act 2000 as amended, for the purposes of which the Issuer is an authorised person carrying on the business of financial services provision. In addition, as a public limited company, the Issuer is subject to the UK Companies Act 2006.

B.4b Known trends affecting the Issuer and the industries in which it operates:

UK real Gross Domestic Product ("GDP") growth slowed from 0.7% quarter-on-quarter in the fourth quarter of 2016 to 0.2% in the first quarter of 2017. Real UK GDP was 2.0% higher than the same quarter a year earlier. The unemployment rate stood at 4.5% in May, a 42-year low. Employment as a percentage of the workforce stood at a record high of 74.9%. However, annual wage growth slowed to 2.1% in the three months to April. The annual rate of growth of the Consumer Price Index ("CPI") measure of inflation stood at 2.9% in May 2017. Activity in the housing market softened, with price growth moderating but remaining positive.

The outlook remains uncertain following the UK electorate’s vote to leave the European Union ("EU") and the invocation of Article 50 (triggering a two-year countdown to leaving) in March 2017. The annual pace of UK real GDP growth is now expected to slow from 1.8% in 2016 to 1.6% in 2017. Investment could be hit by uncertainty over the UK’s future relationship with the EU, and the risk of leaving without a transition deal. CPI inflation is expected to continue to rise, reflecting the fall in sterling’s value. Wages are not expected to grow as fast as inflation, meaning a decline in real incomes, which is expected to weigh on consumption. Offsetting this, net trade has started to improve on the back of the fall in sterling, and government spending may also prove supportive later in the year. Due to higher inflation, some members of the Monetary Policy Committee have already started to vote for rate rises. However, due to weaker growth and an uncertain outlook, the Bank of England base rate is expected to remain low until at least the end of 2018.

The eurozone continues to exhibit modest growth. Real GDP grew by 0.6% in the first quarter of 2017, following growth of 0.4% and 0.5% in the third and fourth quarters of 2016, respectively. Among the four largest eurozone countries, Spain continues to out-perform, with quarterly growth of 0.8% in the first quarter of 2017. Germany grew by 0.6%, while France and Italy each experienced expansions of 0.4%. Household consumption has continued to grow steadily. Although inflation is higher than last year – hitting a 2% annual rate in February, compared to near-zero rates experienced in early 2016 – market sentiment remains firm and unemployment is falling. Investment has picked up sharply, with quarterly growth of 3.4% and 1.3% in the fourth quarter and first quarter respectively. Companies are now playing their part in the recovery as improved confidence and loose credit conditions are supporting investment. Meanwhile the political risks posed by elections in the Netherlands (March) and France (May) have receded.

One possibility is that the eurozone is entering a virtuous circle where higher investment leads to faster productivity growth, rising incomes and improved confidence. But there is still reason

- 11 -


for caution and HSBC Global Research expects GDP growth to accelerate from 1.7% in 2016 to 1.9% in 2017, before easing back to 1.6% in 2018.

CPI inflation peaked at 2.0% in February but has already fallen back to 1.3% in June. With wage growth showing little sign of reacting to a strengthening labour market, the European Central Bank ("ECB") is maintaining its EUR60bn-a-month quantitative easing ("QE") programme. HSBC Global Research expects the ECB to begin ‘tapering’ QE asset purchases in 2018, as the economy continues to recover. That will be preceded by German federal elections in September and, possibly, an early Italian election.

B.5 The group and the Issuer's position within the group:

The whole of the issued ordinary and preference share capital of the Issuer is beneficially owned by HSBC Holdings plc ("HSBC Holdings", together with its subsidiaries, the "HSBC Group"). The Issuer is the HSBC Group's principal operating subsidiary undertaking in Europe.

The HSBC Group is one of the largest banking and financial services organisations in the world, with an international network of more than 4,700 branches in 71 countries and territories across five geographical regions: Europe, Asia, Middle East and North Africa, North America and Latin America. Its total assets as at 31 December 2016 were U.S.$ 2,374,986 million.

B.9 Profit forecast or estimate:

Not applicable. There are no profit forecasts or estimates made in the prospectus.

B.10 Nature of any qualifications in the audit reports on the historical financial information:

Not applicable. There are no qualifications in the audit reports on the audited, consolidated financial statements of the Issuer for the financial years ended 31 December 2015 or 31 December 2016.

B.12 Selected key financial information, no material adverse change and no significant change statement:

The selected key financial information regarding the Issuer set out below has been extracted without material adjustment from the audited consolidated financial statements of the Issuer for the years ended 31 December 2015 and 31 December 2016 and the Unaudited Consolidated Interim Report of the Issuer for the six month period ended 30 June 2017.

Half-year to Year ended

30 June

2017 30 June

2016

31 December

2016

31 December

2015

For the period (£m) Profit/(loss) before tax (reported basis)1 ................... 1,858 2,125 874 2,971 Profit before tax (adjusted basis)1,2,3 ......................... 2,530 1,944 4,234 4,068 Net operating income before loan impairment

charges and other credit risk provisions1,4 ............ 6,913

6,871 13,305 12,870 Profit/(loss) attributable to shareholders of the

parent company1 1,370 1,496

(212) 1,942 At period-end (£m) Total equity attributable to shareholders of the

parent company ..................................................... 41,493 40,823

39,930 37,497

- 12 -


Total assets ................................................................ 832,380 887,661 816,829 727,941 Risk-weighted assets ................................................. 239,703 243,648 245,237 229,382 Loans and advances to customers (net of

impairment allowances) ........................................ 278,214

266,614 272,760 258,506 Customer accounts .................................................... 385,766 363,651 375,252 332,830 Capital ratios (%) Common equity tier 1 ............................................... 10.9 9.6 10.2 9.6 Total tier 1 ................................................................. 13.0 11.6 12.3 11.8 Total capital .............................................................. 16.4 15.3 15.7 15.5 Performance, efficiency and other ratios

(annualised %)

Annualised return on average shareholders' equity

(reported basis)1,5 ................................................... 7.2 8.2 (1.2) 5.9 Return on average risk-weighted assets (reported

basis)1,6 ................................................................... 1.5 1.8

0.4 1.2 Return on average risk-weighted assets (adjusted

basis)1,6 ................................................................... 2.1 1.6

1.7 1.7 Cost efficiency ratio (reported basis)1,7 ................................. 73.3 65.0 90.3 73.2 Cost efficiency ratio (adjusted basis) 1,7 ................................ 63.8 64.1 63.9 64.1 Jaws (adjusted basis)1,8 ......................................................................... 0.5 (7.4) 0.4 0.3 Ratio of customer advances to customer accounts ... 72.1 73.3 72.7 77.7

________________ 1 In late 2016, a macro cash flow hedge was identified as not having met the hedge accounting criteria of IAS 39

during the half-year to 30 June 2016. The hedge was partially discontinued as a result. Profit before tax has been restated to reflect a gain of £134m that should have been transferred from the cash flow hedge reserve to the income statement during the half-year to 30 June 2016.

2 Adjusted performance is computed by adjusting reported results for the effect of significant items as detailed on pages 8 to 10 of the Unaudited Consolidated Interim Report of the Issuer for the six month period ended 30 June 2017.

3 For the half-year ended 31 December 2016, the main adjustment was a £2.2bn impairment of goodwill relating to the Global Banking and Markets ("GB&M") business.

4 Net operating income before loan impairment charges and other credit risk provisions is also referred to as revenue.

5 The return on average total shareholders’ equity is defined as profit attributable to shareholders of the parent company divided by the average total shareholders’ equity.

6 Reported return on average risk-weighted assets ("RoRWA") is calculated using annualised reported profit before tax and reported average risk-weighted assets ("RWAs"). Adjusted RoRWA is calculated using adjusted profit before tax and reported average RWAs, adjusted for the effect of significant items.

7 Reported cost efficiency ratio is defined as total reported operating expenses reported divided by net reported operating income before loan impairment charges and other credit risk provisions, while adjusted cost efficiency ratio is defined as total adjusted operating expenses divided by net adjusted operating income before loan impairment charges and other credit risk provisions. Net adjusted operating income before loan impairment charges and other credit risk provisions is also referred to as adjusted revenue.

8 Adjusted jaws measures the difference between adjusted revenue and adjusted cost growth rates.

There has been no material adverse change in the prospects of the Issuer since 31 December 2016.

There has been no significant change in the financial or trading position of the Issuer and its subsidiary undertakings since 30 June 2017.

B.13 Recent events particular to the Issuer which are to a material extent relevant to the evaluation of the Issuer's solvency:

Not applicable. There have been no recent events particular to the Issuer which are to a material extent relevant to the evaluation of its solvency.

- 13 -


B.14 Dependence upon other entities within the group:

The Issuer is a wholly owned subsidiary of HSBC Holdings.

The Issuer and its subsidiaries form a UK-based group (the "Group"). The Issuer conducts part of its business through its subsidiaries and is accordingly dependent upon those members of the Group.

B.15 The Issuer's principal activities:

The Group provides a comprehensive range of banking and related financial services. The Group divides its activities into four business segments: Retail Banking and Wealth Management; Commercial Banking; Global Banking and Markets; and Global Private Banking.

B.16 Controlling persons:

The whole of the issued ordinary and preference share capital of the Issuer is owned directly by HSBC Holdings.

Section C – Securities

C.1 Description of type and class of securities:

Issuance in series:

Warrants will be issued in series which may comprise one or more tranches. Each Tranche issued under a series will have identical terms, except that different tranches of Warrants may comprise Warrants in bearer form ("Bearer Warrants") or registered form ("Registered Warrants") The issue dates and issue prices under different tranches of Warrants may also vary.

The Warrants being issued are series APAC1189 tranche 1 Warrants (the "Warrants").

All references to "Warrants" in this Summary include Certificates where applicable.

Form of Warrants:

Warrants will be issued in registered form ("Registered Warrants") as certificates and each certificate will carry a unique serial number. Legal title to Warrants will pass by registration of the unique serial number against a Warrantholder's name in a register maintained by, and subject to the regulations of HSBC Bank plc in its capacity as registrar (the "Warrant Registrar").

The Warrants will be represented by

a combined global registered warrant which will be deposited with a common depositary for, and registered in the name of a common nominee for Euroclear Bank S.A./N.V. ("Euroclear") and Clearstream Banking, société anonyme ("Clearstream, Luxembourg")

Security Identification Numbers:

- 14 -


The Warrants have been accepted for clearance through Euroclear and/or Clearstream, Luxembourg and will be allocated the following Security Identification Numbers:

ISIN Code: GB00BZY3HX12

Common Code: 169294992

C.2 Currency of the securities issue:

The settlement currency of the Warrants is USD (the "Settlement Currency").

C.5 Description of any restrictions on the free transferability of the securities:

The Warrants are freely transferable. However, there are restrictions on the offer and sale of the Warrants. The Issuer and HSBC Bank plc (the "Manager") have agreed restrictions on the offer, sale and delivery of the Warrants and on distribution of offering materials in Australia, the Dubai International Financial Centre, the European Economic Area, France, Hong Kong, India, Indonesia, Italy, Japan, the Kingdom of Bahrain, Korea, Malaysia, Mexico, the People's Republic of China, Pakistan, Philippines, Russia, Saudi Arabia, Singapore, Spain, Sri Lanka, Switzerland, Taiwan, Thailand, The Netherlands, the United Arab Emirates (excluding the Dubai International Financial Centre), the United Kingdom, the United States of America and Vietnam. In addition, investors of the Warrants, by their purchase of the Warrants, will be deemed to have given certain representations, warranties, undertakings, acknowledgements and agreements.

C.8

The rights attaching to the securities, including ranking and limitations to those rights:

Cash call options: Warrants give the holder rights, including the right to receive a cash amount from the Issuer calculated by reference to the value of the Underlying. Warrants create call options exercisable by the Warrantholder; there is no obligation upon such Warrantholder to exercise its Warrant nor any obligation upon the Issuer to pay any amount in respect of unexercised Warrants.

Status of the Warrants:

The Warrants will be direct, unsecured and unsubordinated obligations of the Issuer and will rank equally and without preference among themselves and, at their date of issue, with all other unsecured and unsubordinated obligations of the Issuer (unless preferred by law).

Interest Payments:

The Warrants do not bear interest.

Early redemption/termination for illegality:

If the Calculation Agent determines that the performance of the Issuer's obligations has become unlawful or impracticable in whole or in part for any reason, the Issuer will be entitled to terminate the Warrants early and pay the relevant investor an amount per Warrant equal to the fair market value of such Warrant or such other amount specified in the relevant final terms ("Final Terms").

Modification and substitution:

- 15 -


Modifications to the Conditions may be made without the consent of any holders of Warrants to cure any ambiguity or manifest error or correct or supplement any Conditions provided that: (i) the modification is not materially prejudicial to the interest of holders of Warrants; (ii) the modification is of a formal, minor or technical nature or is to correct a manifest error or is to comply with mandatory provisions of the law of the Issuer's jurisdiction of incorporation; or (iii) the modification corrects inconsistency between the Conditions and the relevant termsheet relating to the Warrants. The Warrants permit the substitution of the Issuer with its affiliates without the consent of any holders of Warrants where the Issuer provides an irrevocable guarantee of the affiliate's obligations.

No events of default: There are no events of default applicable to the Warrants.

No guarantee or security:

The Warrants are the obligations of the Issuer only and are unsecured.

Taxation:

All payments by the Issuer in respect of the Warrants will be made without deduction of any taxes, duties and other similar charges, including United Kingdom taxes unless the Issuer is required by law to withhold or deduct any such taxes. Therefore, Warrantholders will be liable for and/or subject to any taxes, duties and other similar charges, including withholding tax, stamp duty, stamp duty reserve tax and/or similar transfer taxes, payable in respect of the Warrants.

Governing Law:

English law.

C.11 Listing and trading:

Application will be made to admit the Warrants to the Official List of the United Kingdom Financial Conduct Authority and to trading on the regulated market of the London Stock Exchange plc.

C.15 Description of how the value of the investment is affected by the value of the underlying instrument:

The Warrants are designed to track the price of the Underlying converted into the currency of the Warrant (if applicable). The Cash Settlement Amount payable on redemption of any Warrant is linked to a fixed amount of the Underlying by way of a hedge in respect of such fixed amount of the Underlying (whether directly or synthetically). In general, as the price of the Underlying increases or decreases, so will the Cash Settlement Amount payable in respect of such Warrants. Similarly, changes in the value of the relevant currency rate will change the value of the Warrants.

The quoted price of the Underlying converted into the currency of the Warrant (if applicable) may diverge from the Cash Settlement Amount payable under the Warrant owing to disparity between any hedge and the Underlying, and to the deduction of costs, such as, amongst other things, brokers fees, transaction processing fees and actual and potential taxes, duties and other

- 16 -


similar charges, including those costs that would be incurred by the Issuer and/or its designated affiliates of hedging the Underlying, whether directly or synthetically, and a fee to be retained by the Issuer, the Manager(s) and/or their affiliates.

The Warrants can only be acquired for consideration of at least EUR 100,000 (or its equivalent in another currency) per Warrant.

C.16 Expiration or maturity date of securities:

The Warrants will be cash-settled.

The expiry date in respect of the Warrants is 23 November 2020 (the "Expiry Date"). The Warrants are:

"American Style Warrants" and are therefore exercisable on any Business Day during the period beginning on (and including) the Issue Date and ending on (and including) the Expiry Date.

C.17 Settlement procedure:

The Warrants will be cash-settled.

All payments to Warrantholders will be paid through Euroclear and/or Clearstream, Luxembourg.

C.18 Return on securities:

The Warrants are "Underlying Security-Linked Warrants" and are linked to a single underlying security (the "Underlying")

The Warrants are market access products, which are designed for investors who wish to be exposed to fluctuations in the price of the Underlying, but who do not wish to or are not able to hold the relevant Underlying itself. In addition, the Warrants are designed to allow investors to get exposure to the Underlying even though it may be priced locally in a less accessible currency or currencies.

There are two types of payment a Warrantholder will receive under the Warrants: the "Cash Settlement Amount" and any "Additional Payments".

Payments at maturity or on exercise

The Warrants will have a Cash Settlement Amount which will be calculated in a different manner depending on whether the Warrants are Underlying ETF-Linked Warrants, Underlying Fund-Linked Warrants, Underlying Index-Linked Warrants or Underlying Security-Linked Warrants.

The Warrants are Underlying Security-Linked Warrants and accordingly the Cash Settlement Amount will be the Net Realisable Sale Price per Warrant minus the Strike Price (USD 0.000001). The Realisable Sale Price per Warrant will be equal to:

if the Issuer or any of its affiliate(s) hold the underlying assets and dispose of them, the amount per Warrant received from such disposal, less any costs and converted into the currency of the Warrant (if applicable);

if neither the Issuer nor any of its affiliate(s) hold the underlying assets but is party to a hedge or other

- 17 -


arrangement relating to the Warrants being exercised, the effective price at which such hedge or other arrangement was realised or unwound, less any costs and converted into the currency of the Warrants (if applicable); or

if neither the Issuer nor any of its affiliate(s) hold the underlying assets nor are party to a hedge or other arrangement relating to the Warrants being exercised, the amount per Warrant a notional, direct holder of the underlying assets of the Warrants would receive from disposing of them on expiry, less any costs and converted into the currency of the Warrant (if applicable).

If the actual or notional amounts received need to be converted into the currency of the Warrant, the rate of exchange used will be either:

if the Issuer or its affiliate(s) has an exchange transaction (whether implicit as part of a hedge or other arrangement for the underlying assets or as part of a separate arrangement), the rate of exchange obtained under that arrangement; or

if the Issuer or its affiliate(s) has not entered into an exchange transaction the rate of exchange which a notional, direct holder of the underlying assets of the Warrants would be able to obtain.

Additional Payments

If the Warrants are Underlying Security-Linked Warrants, then holders of Warrants will also potentially be entitled to Additional Payments.

The Warrants are Underlying Security-Linked Warrants and the Additional Payments payable to holders of Warrants will be:

if the Issuer or its affiliate(s) hold the appropriate underlying assets (that is, the shares), the aggregate amount of the net cash dividend or distribution received;

if the Issuer or its affiliate(s) hold a hedge or other arrangement for the purposes of performing its obligations under the Warrants, the net cash dividend or distribution equivalent payment received under the hedge or other arrangement;

if the Issuer or its affiliate(s) do not hold any of the underlying assets or are not party to a hedge or other arrangement relating to the Warrants, the net amount a notional, direct holder of the underlying assets relating to the Warrants would receive by way of cash dividend or distribution; or

if a non-cash dividend or distribution is made, the Issuer may in its absolute discretion, pay to the Warrantholders the net cash value of such non-cash dividend or

- 18 -


distribution or, if the Issuer or its affiliate(s) holds a hedge or other arrangement relating to the Warrants, the net cash adjustment or settlement received in respect of such non-cash dividend or distribution under such hedge or other arrangement, in respect of the underlying securities, such as an issue of warrants or preference shares,

in all cases, less any costs and converted into the currency of the Warrants (if applicable).

If the actual or notional amounts need to be converted into the currency of the Warrant, the rate of exchange used is either:

if the Issuer or its affiliate(s) has an exchange transaction (whether implicit as part of a hedge or other arrangement for the underlying assets or as part of a separate arrangement), the rate of exchange obtained under that arrangement; or

if the Issuer or its affiliate(s) has not entered into an exchange transaction, that which a notional, direct holder of the underlying assets of the Warrants would be able to obtain.

Supplementary Amounts:

Supplementary Amounts do not apply to this series of Underlying Security-Linked Warrants.

Interest Payments:


C.19 Exercise price or final reference price of the underlying:

The calculations which are required to be made to calculate the Cash Settlement Amount will be based on the value of the Underlying determined by the Calculation Agent being HSBC Bank plc. The Calculation Agent will determine the value of the Underlying by reference to the actual or notional value upon disposal or realisation of the Underlying or the value of realising or unwinding a hedge or other arrangement in respect of such Underlying, in all cases deducting costs and converting into the currency of the Warrant (if applicable).

Interest Payments:


C.20 Type of the underlying:

Each series of Warrants is linked to the performance of one of the following:

a security or basket of securities (together, the "Underlying Securities" and each, an "Underlying Security") issued by a company or companies (together, the "Underlying Companies" and each, an "Underlying Company") which is/are listed and/or admitted to trading on one or more stock exchanges (such Warrants are referred to as, "Underlying Security-Linked Warrants"); or

- 19 -


a security or basket of securities (together, the "China Connect Underlying Securities" and each, a "China Connect Underlying Security") issued by a company or companies (together, the "Underlying Companies" and each, an "Underlying Company") which is, or is expected to be, listed and/or admitted to trading on any stock exchange (each a "China Connect Market") in the People's Republic of China ("PRC", which shall for the purposes of this document exclude Hong Kong, Macau or Taiwan) under any securities trading and clearing links developed or to be developed by The Stock Exchange of Hong Kong Limited ("SEHK"), any such China Connect Market, the Hong Kong Securities Clearing Company Limited and the China Securities Depository and Clearing Corporation for the establishment of mutual market access between SEHK and any such China Connect Market (such Warrants are referred to as " China Connect Underlying Security-Linked Warrants"); or

an index or basket of indices (together, the "Underlying Indices" and each, an "Underlying Index") being composed of certain securities (together, the "Component Securities" and each, a "Component Security") (such Warrants are referred to as, "Underlying Index-Linked Warrants"); or

a fund or basket of funds (together, the "Underlying Funds" and each, an "Underlying Fund") (such Warrants are referred to as, "Underlying Fund-Linked Warrants"); or

an exchange-traded fund or a basket of funds (together, the "Underlying ETFs" and each, an "Underlying ETF") which is/are listed and/or admitted to trading on one or more stock exchanges (such Warrants are referred to as, "Underlying ETF-Linked Warrants").

The Warrants are Underlying-Security Linked Warrants, being Warrants in relation to which the Cash Settlement Amount is linked to one security, namely Meinian Onehealth Healthcare Holdings Co Ltd. Underlying Security Linked Warrants are also referred to in the prospectus as "Underlying Equity-Linked Warrants".

References to "Underlying", either in the singular or plural form, shall refer to any Underlying applicable to a series of Warrants.

Information on the Underlying can be found on Bloomberg under 002044 CH.

Section D – Risks

D.2 Key risks specific to the Issuer:

A description of the key risk factors relating to the Issuer that may affect the ability of the Issuer to fulfil its obligations to investors in relation to any of its debt or derivative securities is set out below.

- 20 -

Section D – Risks

Current economic and market conditions could materially adversely affect the Issuer:

The Issuer's earnings are affected by global and local economic and market conditions. Uncertain and at times volatile economic conditions can create a challenging operating environment for financial services companies such as the Issuer, including challenges arising from any of the following: reduced demand for borrowing from creditworthy customers; the imposition of protectionist measures; renewed stress as subdued economic conditions raise asset quality concerns, and uncertainties about the EU bank resolution regime raise funding costs; a prolonged period of low or negative interest rates constraining the amount of the Issuer's net interest income; market disruption adversely affecting funding transactions and the Issuer's ability to borrow from other financial institutions; subdued economic growth and/or asset valuation bubbles as a result of too rapid growth.

The UK's withdrawal from the EU may adversely affect the Issuer's operating model and financial results

The UK electorate's vote to leave the EU may have a significant impact on general macroeconomic conditions in the UK, the EU and globally, and is likely to usher in a prolonged period of uncertainty. Negotiations of the UK's exit agreement, its future relationship with the EU and its trading relationships with the rest of the world will likely take a number of years to resolve. The period of uncertainty and market volatility that followed the UK's decision to leave the EU is likely to continue until the UK's future relationship with the EU and the rest of the world is clearer. Given the timeframe and the complex negotiations involved, a clearer picture is not expected to emerge for some time.

Uncertainty as to the precise terms of these arrangements, and the future legal and regulatory landscape, may lead to uncertain economic conditions, market volatility and currency fluctuations. Among other issues, the UK's future relationship with the EU may have implications for the future business model for the Issuer's London-based European cross-border banking operations, which relies on unrestricted access to the European financial services market.

The Issuer's parent company is subject to regulatory commitments and consent orders:

HSBC Holdings is subject to a deferred prosecution agreement with the US Department of Justice and related agreements and consent orders with US and UK government agencies to comply with certain remedial measures with respect to the HSBC Group’s anti-money laundering and sanctions compliance programmes, including the appointment of an independent compliance monitor. Failure to comply with the terms of such agreements may have a material adverse effect on the Group, including loss of business and withdrawal of funding, restrictions on performing dollar-clearing functions, or revocation of bank licences.

- 21 -

Section D – Risks

UK banking structural reform legislation and proposals could materially adversely affect the Issuer:

Material changes to the corporate structure and business activities of the Issuer, including the establishment of a separate ring-fenced bank for retail banking activities, are expected pursuant to UK banking structural reform legislation and proposals. The restructuring will involve the transfer of qualifying components of the Issuer's UK Retail Banking and Wealth Management, Commercial Banking and Global Private Banking businesses from the Issuer to a new legal entity, HSBC UK. The Issuer expects the cost of implementing these plans to be material. In addition to the restructuring costs, the Issuer will have a reduced balance sheet, including a reduction in risk-weighted assets, and a reduced and potentially more volatile revenue stream. These structural changes could result in changes to the Issuer's credit rating and increases in its cost of funding.

The Issuer is subject to a number of legal and regulatory actions and investigations:

The Issuer is subject to a number of legal and regulatory actions and investigations, the outcomes of which are inherently difficult to predict. An unfavourable result in one or more of these could result in the Issuer incurring significant expense, substantial monetary damages, loss of significant assets, other penalties and injunctive relief, potential regulatory restrictions on the Issuer's business and/or a negative effect on the Issuer's reputation.

Unfavourable legislative or regulatory developments, or changes in the policy of regulators or governments could materially adversely affect the Issuer:

The Issuer's businesses are subject to ongoing regulation and associated regulatory risks, including the effects of changes in the laws, regulations, policies, guidance, voluntary codes of practice and their interpretations in the UK, the EU and the other markets in which the Issuer operates. This is particularly so in the current environment, where the Issuer expects government and regulatory intervention in the banking sector to remain high for the foreseeable future.

The Issuer is subject to the substance and interpretation of tax laws in the jurisdictions in which it and members of the Group operate:

The Issuer is subject to the substance and interpretation of tax laws in all countries in which it and members of the Group operate, the risk associated with changes in tax law or in the interpretation of tax law, the risk of changes in tax rates and the risk of consequences arising from failing to comply with procedures required by tax authorities.

The Issuer's operations are highly dependent on its information technology systems:

The reliability and security of the Issuer's information and technology infrastructure and the Issuer's customer databases are crucial to maintaining the service availability of banking

- 22 -

Section D – Risks

applications and processes and to protecting the HSBC brand. Critical systems failure, prolonged loss of service, cyber-attacks, or internet crime or a material breach of security could lead to financial loss and cause damage to the Issuer's business and brand.

The Issuer's operations have inherent reputational risk:

Reputational risk may arise from negative public opinion about the actual or perceived manner in which the Issuer conducts its business activities, its financial performance, as well as actual or perceived practices in banking and the financial services industry generally. Negative public opinion may adversely affect the Issuer's ability to keep and attract customers and, in particular, corporate and retail depositors, and retain and motivate staff which in turn could have a material adverse effect on the Issuer.

The Issuer has significant exposure to counterparty risk:

The Issuer's ability to engage in routine transactions to fund its operations and manage its risks could be materially adversely affected by the actions and commercial soundness of other financial services institutions. Financial services institutions are necessarily interdependent because of trading, clearing, counterparty or other relationships, which could affect a financial services institution's funding and its ability to manage the risks of its business.

Market fluctuations may reduce the Issuer's income or the value of its portfolios:

The Issuer's businesses are exposed to changes in, and increased volatility of, interest rates, inflation rates, credit spreads, foreign exchange rates, commodity, equity, bond and property prices and the risk that the Issuer's customers act in a manner inconsistent with its business, pricing and hedging assumptions. It is difficult to predict with any accuracy changes in market conditions, and such changes could have a material adverse effect on the Issuer.

Liquidity, or ready access to funds, is essential to the Issuer's business:

If the Issuer is unable to raise funds, its liquidity position could be adversely affected and the Issuer might be unable to meet deposit withdrawals or obligations under committed financing facilities and insurance contracts, to fund new loans, investments and businesses or to repay borrowings as they mature.

Any reduction in the credit rating of the Issuer or any of its debt securities could affect the availability of the Issuer's funding and affect its liquidity position and interest margins:

Credit ratings affect the cost and other terms upon which the Issuer is able to obtain market funding. Rating agencies regularly evaluate the Issuer, as well as its respective debt securities. There can be no assurance that the rating agencies will maintain the Issuer's current ratings or outlook. Any reductions in these ratings and outlook could increase the cost of the Issuer's funding, limit

- 23 -

Section D – Risks

access to capital markets and require additional collateral to be placed.

D.6 Key risks specific to the securities and risk warning to the investor:

Credit risk: The Warrants are direct, unsubordinated and unsecured obligations of the Issuer and not of any other person. If the Issuer's financial position were to deteriorate, there could be a risk that the Issuer would not be able to meet its obligations under the Warrants (the Issuer's credit risk). If the Issuer becomes insolvent or defaults on its obligations under the Warrants, in the worst case scenario, investors in the Warrants could lose all of their invested amounts.

The Warrants are unsecured obligations: The Warrants are not secured over any asset. Therefore, the investor would not be able to enforce security as a method of recouping payments due under the Warrants if the Issuer were to become insolvent and cease to be able to pay such amounts.

The Warrants are not ordinary debt securities: The Warrants do not pay interest and, upon redemption, expiry or upon exercise (as applicable), may return less than the amount invested or nothing. The Warrants are designed to track the price or level of the Underlying. If the performance of such Underlying does not move in the anticipated direction or if the issuer thereof becomes insolvent, the Warrants will be adversely affected and, in a worst case scenario, may become worthless.

Payments under the Warrants may be delayed: Payments to holders of Warrants which are calculated by reference to hedging arrangements will only be due if the proceeds would have been received by an investor outside the jurisdiction where the Underlying is listed or quoted. There is a risk that limitations on the importation and withdrawal of funds in such jurisdiction could lead to potential delays in payments under the Warrants or, in the worst case, the Warrants becoming worthless.

No ownership rights: The Warrants do not confer any legal or beneficial interest or any voting or dividend rights in the Underlying or the Component Securities.

Suspension of Issuer's payment obligation: Payments to holders of Warrants may be suspended so long as dealings in the relevant Underlying and related hedging transaction are or are wholly to be prevented, delayed or restricted by the closure of a relevant exchange or the suspension of trading or the occurrence of other circumstances, or if any circumstances arise which adversely affect the ability to carry out foreign exchange transactions or currency transfers. In the event of such suspension, Warrantholders will not be entitled to any interest or other compensation in respect of the suspension.

There may be no active trading market or secondary market for liquidity for the Warrants: Any series of Warrants may not be widely distributed and there may not be an active trading market, nor is there assurance as to the development of an active trading market. If there is no liquid market, investors may not be able to realise their investment until specified exercise dates of the Warrants (as applicable) or may not realise a return that equals or exceeds the purchase price of their Warrants. Notwithstanding

- 24 -

Section D – Risks

the foregoing, the Issuer may issue Warrants which provide for certain circumstances where the Issuer may buy-back such Warrants (as applicable) from the holders of such securities.

Certain factors affecting the value and trading price of Warrants: The Cash Settlement Amount payable (as applicable) under the Warrants may be affected by fluctuations in value of the Underlying or the Component Securities, changes in currency exchange rates, changes in interest rates, volatility of the Underlying, time remaining to expiry, dividend rates on the Underlying or the Component Securities or, where applicable, the number and type of Underlyings included in a basket to which the relevant Warrants relate.

Conflicts of interest may arise between the interests of the Issuer or its affiliates and those of the holders of the Warrants: The Issuer or its affiliates may enter into hedging or other transactions (i) relating to Underlyings or the Component Securities or (ii) with issuers of Underlyings or the Component Securities. The Issuer or its affiliates may also publish research or other reports relating to Underlyings or the Component Securities. Any such activities may have a negative effect on the value of Warrants relating to such Underlyings. In addition, the Issuer may assume roles as hedging party, service providers or calculation agent in respect of Underlyings which are funds, calculation agent under the Warrants or publisher of research reports. In respect of any of these roles the Issuer may have interests that conflict with the interests of holders of such securities.

Commission and cost of hedging: The issue price of the Warrants may include commissions charged by Issuer or its affiliates and the cost or expected costs of hedging the Issuer's obligations under the Warrants (if any). Accordingly, there is a risk that, upon issue, the market price of Warrants may be lower than the original purchase price of the Warrants. Also, fees, commission and hedging costs may be deducted from the Cash Settlement Amount in the case of Warrants.

Exchange rate risks and exchange control risk: The Issuer will pay amounts in respect of the Warrants in the Settlement Currency. Since the Underlying is referenced in CNY (the "Underlying Currency"), amounts payable under the Warrants may be affected by multiple currency conversion costs which may be passed on to investors. Where the Settlement Currency is not the same as the investor's home currency, the realisable value of the investment in the investor's home currency may be at risk from fluctuations in the exchange rate. Government and monetary authorities may impose or modify exchange controls that could adversely affect an applicable exchange rate or transfer of funds in and out of the country. As a result of such restrictions and controls the Issuer may suspend its obligations to make any payment under any Warrants if and for as long as such exchange controls have occurred and are continuing. Holders of the Warrants shall not be entitled to any interest or other compensation in respect of any such suspension.

- 25 -

Section D – Risks

Market Disruption Events and Additional Disruption Events: In the case of early closure of the relevant exchange, disruption of such exchange or suspension of trading on such exchange, including, in the case of Warrants linked to a China Connect Underlying, including the early closure or disruption of the securities trading and clearing links programme developed or to be developed by The Stock Exchange of Hong Kong Limited (the "SEHK"), the China Connect Market, the Hong Kong Securities Clearing Company Limited and the China Securities Depository and Clearing Corporation for the establishment of mutual market access with SEHK and the China Connect Market, where applicable ("Market Disruption Events") or a hedging disruption, a change in applicable laws, an increased cost of hedging, where applicable, an insolvency filing of the issuer of the Underlying, a foreign exchange disruption event, or, in the case of Warrants linked to a China Connect Underlying, a ceasing by the relevant exchange to accept Securities as "China Connect" securities, or a permanent suspension or termination of the "China Connect" service with respect to the Securities ("Additional Disruption Events"), postponement or adjustment of valuations in case of a Market Disruption Event or adjustment of terms as agreed to by the holders of Warrants or redemption or exercise of the Warrants in case of an Additional Disruption Event in respect of such Warrants may have an adverse effect on the value of and/or the Cash Settlement Amount in respect of such Warrants.

Illegality or changes in tax law may cause the Issuer's obligations under the Warrants to be redeemed or terminated early: If the Calculation Agent determines the performance of the Issuer's obligations under any Warrants shall have become unlawful or impracticable, the Issuer may terminate its obligations under such Warrants and pay a sum representing the fair market value of such Warrants. As a result holders of Warrants will forgo any future appreciation in the relevant Underlying, may suffer a loss of some or all of their investments and lose the ability to exercise the Warrants on the relevant exercise date(s) (if applicable).

Considerations regarding hedging: The value of the Warrants may not exactly correlate with the value of the Underlying to which the Warrants relate.

Applicable Bank Resolution Powers: The Issuer is subject to the Banking Act 2009 which implements the BRRD in the UK and gives wide powers in respect of UK banks and their parent and other group companies to HM Treasury, the Bank of England, the Prudential Regulation Authority and the United Kingdom Financial Conduct Authority (each, a "relevant UKRA") in circumstances where a UK bank has encountered or is likely to encounter financial difficulties. These powers include a "bail-in" power, which gives the relevant UKRA the power to cancel all or a portion of the principal amount of, or interest on, certain unsecured liabilities (which could include the Warrants) of a failing financial institution, to convert certain debt claims (which could be amounts payable under the Warrants) into another security (including common shares), or alter the terms of such liabilities, including their maturity or expiry or the date on which interest becomes payable, including by suspending payments for

- 26 -

Section D – Risks

a temporary period. The exercise by the relevant UKRA of any of its powers under the Banking Act 2009 (including especially the bail-in power) could lead to the holders of the Warrants losing some or all of their investment or may adversely affect the rights of holders of the Warrants, the market value thereof or the Issuer's ability to satisfy its obligations thereunder.

Tax risks: The amount of a payment to the investor under the Warrants may be decreased to take into account the effect of taxes, duties or other similar charges on an investment in the Underlying. There is a risk that tax law or practice will change in the future resulting in the imposition of or increase in tax on an investment in, or disposition of the Underlying. This will result in a decrease of the amounts payable under the Warrants. Also, investors in the Warrants will be obliged to pay all taxes, duties or other similar charges payable in connection with the subscription, purchase or holding of such Warrant and the payment of the Cash Settlement Amount and/or any Additional Payment.

Emerging market risks: Investors in Warrants relating to Underlyings which are issued in or located in or listed on an exchange in an emerging market, namely the PRC, should be aware that investments in emerging markets, and specifically the PRC, are subject to greater risks than well-developed western markets. Institutions relied upon for the efficient functioning of capital markets, such as stock exchanges, economic, legal and regulatory institutions, systems for the clearing, settlement and registration of securities, may be less developed. Disclosure standards may be less onerous on issuers and accountancy practices may differ from those which are internationally accepted. Political conditions in certain geographic locations where the issuers of Underlyings may operate may be volatile or unstable, and there could be increased price volatility.

Specific risks relating to Underlying Equity-Linked Warrants: If a Potential Adjustment Event occurs and dilutes the theoretical value of the Underlying or an Extraordinary Event occurs, the Calculation Agent may make corresponding adjustments to the conditions of the Warrants which may adversely affect the Cash Settlement Amount payable or (in the case of Extraordinary Events) may terminate the Warrants; as a result the holder of Warrants may lose some or all of its investment.

Investors may lose the value of their entire investment or part of it, as the case may be.

Section E – Offer

E.2b Reasons for the offer and use of proceeds when different from making profit and/or hedging certain risks:

Not applicable. The prospectus has been prepared solely in connection with the admission of Warrants to trading on a regulated market pursuant to Article 3(3) of the Prospectus Directive. There will be no public offer of the Warrants and thus reasons for the offer and use of proceeds are not required.

- 27 -

939416996.4

Section E – Offer

E.3 Description of the Terms and conditions of the offer:

Not applicable. The prospectus has been prepared solely in connection with the admission of Warrants to trading on a regulated market pursuant to Article 3(3) of the Prospectus Directive. There will be no public offer of the Warrants and thus a description of the terms and conditions of the offer is not required.

E.4 Description of any interests material to the issue/offer, including conflicting interests:

The Issuer or its affiliates may engage in hedging or other transactions involving the relevant Underlying which may have a positive or negative effect on the value of such Underlying and therefore on the value of any Warrants to which they relate. Certain affiliates of the Issuer may also be the counterparty to the hedge of the Issuer's obligations under an issue of Warrants and the Calculation Agent is responsible for making determinations and calculations in connection with the Warrants in its sole and absolute discretion acting in good faith. The Issuer or its affiliates may from time to time advise the issuer or obligors of, or publish research reports relating to, an Underlying. The views or advice may have a positive or negative effect on the value of an Underlying and may be inconsistent with purchasing or holding the Warrants relating to such an Underlying.

Fees may be payable by the Issuer to the Manager acting as underwriter(s) of issues of the Warrants.

Save as disclosed above, no person involved in the issue of the Warrants has, so far as the Issuer is aware, an interest material to the issue.

E.7 Estimated expenses charged to the investor by the Issuer or the offeror:

Not applicable. The prospectus has been prepared solely in connection with the admission of Warrants to trading on a regulated market pursuant to Article 3(3) of the Prospectus Directive. There will be no public offer of the Warrants and expenses in respect of the listing of Warrants are not charged directly by the Issuer to the investor.

hsbc bank plc programme for the issuance of …...final terms dated: 28 september 2017 series no.:...

Documents